Skip to main content

Table 1 The baseline characteristics of all study participants

From: Survival of Chinese people with type 2 diabetes and diabetic kidney disease: a cohort of 12 -year follow-up

 TotalMicroalbuminuriaOvert albuminuriaP value
Male gender (n, %)217 (48.8)170 (48.4)47 (50.0)0.817
Age at registration (years) a57.5 ± 11.657.2 ± 11.658.4 ± 11.30.397
Age at onset (years) a48.8 ± 11.049.3 ± 10.847.1 ± 11.60.085
Diabetes duration (years) b8.0(4.0, 13.0)7.0 (2.5, 12.0)10.0 (8.0, 15.0)0.000
DM family history192 (43.2)152 (43.4)40 (42.6)0.907
Smoke (n, %)138 (31.4)104 (30.1)34 (36.2)0.263
Hypertension (n, %)265 (59.8)200 (57.1)65 (69.9)0.032
BMI (Kg/m2) a26.2 ± 3.826.3 ± 3.925.8 ± 3.40.225
SBP (mmHg) b130 (120, 145)130 (120, 140)140 (120, 151)0.020
DBP (mmHg) b80 (80, 90)80 (80, 90)80 (80, 90)0.408
eGFR (ml/min) a77.1 ± 28.464.6 ± 32.380.5 ± 26.30.000
Total cholesterol (mmol/L) a4.99 ± 1.314.93 ± 1.295.21 ± 1.370.067
Triglycerides (mmol/L) b1.72 (1.12, 2.71)1.70 (1.11, 2.73)1.86 (1.23, 2.51)0.563
LDL cholesterol (mmol/L) a3.05 ± 0.993.00 ± 0.953.21 ± 1.150.109
HDL cholesterol (mmol/L) a1.10 ± 0.381.09 ± 0.391.14 ± 0.310.334
Uric acid (μmol/L) a296.4 ± 103.1286.1 ± 103.3333.8 ± 93.70.000
HbA1c (mmol/mol) a82 ± 2683 ± 2577 ± 270.035
FPG (mmol/L) a10.2 ± 4.010.3 ± 4.09.5 ± 4.00.060
Hypertension (n, %)265 (59.8)200 (57.1)65 (69.9)0.032
Use of ACE inhibitor/ARB (n, %)315 (70.8)242 (68.9)73 (77.7)0.125
Diabetic retinopathy (n, %)108 (27.6)78 (24.5)30 (41.1)0.006
Peripheral vascular disease (n, %)285 (80.1)206 (79.5)79 (81.4)0.845
Mean age at death (years) a70.1 ± 9.170.6 ± 8.968.8 ± 9.70.437
  1. aData shown as mean ± SD
  2. bData are medians (IQR)